Literature DB >> 12120003

Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus.

Philip D Hardt1, Annegret Killinger, Jens Nalop, Henning Schnell-Kretschmer, Tobias Zekorn, Hans U Klör.   

Abstract

BACKGROUND: Pancreatic exocrine dysfunction has been described frequently in IDDM and NIDDM patients. Most authors tried to explain this finding as a diabetic complication. On the other hand, diabetes secondary to chronic pancreatitis (CP) might be more common than believed so far. AIM OF THE STUDY: In this study we evaluated pancreatograms of patients with known diabetes mellitus in order to detect ductal morphology changes characteristic for CP.
METHODS: Consecutive diabetic patients admitted for ERCP for different reasons were evaluated retrospectively concerning ERCP findings, especially pancreatic duct changes (Cambridge classification), diabetes type, duration and therapy.
RESULTS: 156 patients (76 male, 80 female; mean age 60 years (19-93)) were studied (38 IDDM; 118 NIDDM). Pancreatic ducts were classified as normal in 23.3%, CP degree I in 22.7%, CP degree II in 32.7% and CP degree III in 21.3%. The duct changes did not correlate with diabetes type (p = 0.19), diabetes duration (p = 0.38), diabetes therapy (p = 0.5) or age (p = 0.48).
CONCLUSION: Since CP should be defined by morphological and functional changes, it must be concluded that a substantial number of patients with a primary diagnosis of diabetes mellitus may have CP as a concomitant disease or, more likely, as a cause for their diabetic state.

Entities:  

Mesh:

Year:  2002        PMID: 12120003     DOI: 10.1159/000049445

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  14 in total

1.  Characterization of human organ donors testing positive for type 1 diabetes-associated autoantibodies.

Authors:  A Wiberg; A Granstam; S Ingvast; T Härkönen; M Knip; O Korsgren; O Skog
Journal:  Clin Exp Immunol       Date:  2015-10-06       Impact factor: 4.330

Review 2.  Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy: Conclusions From a Review of Literature.

Authors:  Sonmoon Mohapatra; Shounak Majumder; Thomas C Smyrk; Lizhi Zhang; Aleksey Matveyenko; Yogish C Kudva; Suresh T Chari
Journal:  Pancreas       Date:  2016-09       Impact factor: 3.327

Review 3.  [Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Sandra Zlamal-Fortunat; Heinz F Hammer
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

Review 4.  The role of fecal elastase-1 in detecting exocrine pancreatic disease.

Authors:  John S Leeds; Kofi Oppong; David S Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05-31       Impact factor: 46.802

Review 5.  Structure and function of the exocrine pancreas in patients with type 1 diabetes.

Authors:  Laure Alexandre-Heymann; Roberto Mallone; Christian Boitard; Raphaël Scharfmann; Etienne Larger
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

Review 6.  Relationship between the exocrine and endocrine pancreas after acute pancreatitis.

Authors:  Stephanie L M Das; James I C Kennedy; Rinki Murphy; Anthony R J Phillips; John A Windsor; Maxim S Petrov
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

7.  [Position paper: Exocrine pancreatic insufficiency and diabetes mellitus].

Authors:  Raimund Weitgasser; Heidemarie Abrahamian; Martin Clodi; Werner Fortunat; Heinz Hammer
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

8.  High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study.

Authors:  Philip D Hardt; Annette Hauenschild; Clemens Jaeger; Joachim Teichmann; Reinhard G Bretzel; Hans U Kloer
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

9.  The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss.

Authors:  Feng X Li; Jing W Zhu; Jeffery S Tessem; Joshua Beilke; Marileila Varella-Garcia; Jan Jensen; Christopher J Hogan; James DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

10.  Critical roles for macrophages in islet angiogenesis and maintenance during pancreatic degeneration.

Authors:  Jeffery S Tessem; Jan N Jensen; Hanna Pelli; Xu-Ming Dai; Xiao-Hua Zong; E Richard Stanley; Jan Jensen; James DeGregori
Journal:  Diabetes       Date:  2008-03-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.